CIM
Calvert Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-4,592
| Closed | -$1.69M | – | 472 |
|
2016
Q4 | $1.69M | Sell |
4,592
-162
| -3% | -$59.5K | 0.06% | 312 |
|
2016
Q3 | $1.91M | Buy |
4,754
+87
| +2% | +$35K | 0.07% | 299 |
|
2016
Q2 | $1.63M | Buy |
4,667
+182
| +4% | +$63.6K | 0.07% | 277 |
|
2016
Q1 | $1.62M | Buy |
4,485
+458
| +11% | +$165K | 0.07% | 251 |
|
2015
Q4 | $2.19M | Buy |
4,027
+840
| +26% | +$456K | 0.1% | 191 |
|
2015
Q3 | $1.48M | Buy |
3,187
+160
| +5% | +$74.4K | 0.07% | 176 |
|
2015
Q2 | $1.54M | Sell |
3,027
-260
| -8% | -$133K | 0.07% | 187 |
|
2015
Q1 | $1.48M | Buy |
3,287
+323
| +11% | +$146K | 0.1% | 185 |
|
2014
Q4 | $1.22M | Buy |
2,964
+255
| +9% | +$105K | 0.08% | 199 |
|
2014
Q3 | $977K | Buy |
2,709
+1,955
| +259% | +$705K | 0.07% | 206 |
|
2014
Q2 | $213K | Hold |
754
| – | – | 0.01% | 334 |
|
2014
Q1 | $226K | Buy |
754
+1
| +0.1% | +$300 | 0.02% | 321 |
|
2013
Q4 | $207K | Hold |
753
| – | – | 0.02% | 324 |
|
2013
Q3 | $236K | Buy |
+753
| New | +$236K | 0.03% | 283 |
|